Celtic Pharma Holdings Advisors makes appointment
This article was originally published in Scrip
Executive Summary
Celtic Pharma Holdings Advisors, a private equity fund management partnership focused on the biotechnology and pharmaceutical industries, and advisor to the second Celtic Pharma fund, has appointed Dr Andy Richards to its advisory board. He is chairman of Altacor and Novacta Biosciences, and a non-executive director of Vectura Group, Summit, Biowisdom, Babraham Bioscience Technology, Cancer Research Technology and Arecor. Dr Richards has also advised the UK Government's Office of Life Sciences, which is led by the minister for science and innovation Lord Drayson, and UK Trade & Investment on biotechnology issues.